IRTC
iRhythm Technologies, Inc.
IRTC lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
IRTC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Unavailable |
IRTC's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
IRTC PE Valuation
IRTC has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 100x next year's earnings.
IRTC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IRTC to return to profit, with revenue growing. However, they disagree widely on these estimates.
IRTC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.93 | — |
| Q3 2026 | -$1.16 | +$0.44 |
| Q2 2026 | -$0.42 | +$2.50 |
| Q1 2026 | -$0.85 | +$2.28 |
| Q4 2025 | -$1.39 | +$2.24 |
| Q3 2025 | -$1.60 | +$3.25 |
| Q2 2025 | -$2.92 | +$1.34 |
| Q1 2025 | -$3.13 | +$1.09 |
| Q4 2024 | -$3.63 | +$0.41 |
IRTC is still losing money, but far less than before: $1.16 per share over the past year, against $4.85 at its worst in late 2024.
IRTC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $221.6M | +15% |
| Q2 2026 | $224.2M | +20% |
| Q1 2026 | $199.4M | +26% |
| Q4 2025 | $208.9M | +27% |
| Q3 2025 | $192.9M | +31% |
| Q2 2025 | $186.7M | +26% |
| Q1 2025 | $158.7M | +20% |
| Q4 2024 | $164.3M | +24% |
IRTC's revenue has grown year over year every quarter since late 2020: $222M last quarter, up 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -15% | -10 points |
| Q2 2026 | -1.1% | +8.9 points |
| Q1 2026 | -8.1% | +12 points |
| Q4 2025 | 1.1% | +3.6 points |
| Q3 2025 | -4.4% | +30 points |
| Q2 2025 | -10% | +5.5 points |
| Q1 2025 | -21% | +8.4 points |
| Q4 2024 | -2.5% | +27 points |
IRTC's operating margin was −15% last quarter, down 10 points from the same quarter a year ago.
IRTC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$11.5M | -158% |
| Q2 2026 | $37.5M | +117% |
| Q1 2026 | -$33.1M | -$15.8M |
| Q4 2025 | $14.5M | +17% |
| Q3 2025 | $20.1M | +29% |
| Q2 2025 | $17.3M | +416% |
| Q1 2025 | -$17.3M | +$44.5M |
| Q4 2024 | $12.4M | +$41.9M |
IRTC has burned cash in most quarters: $7M over the past year, down 77% from the year before.
IRTC Net Leverage
IRTC's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
IRTC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.6 | Neutral |
| Stochastic | 29.9 | Neutral |
IRTC's weekly RSI is 38 (neutral) and its Stochastic is 30 (neutral).
IRTC PE vs Healthcare Sector
IRTC has no meaningful PE right now: it lost money over the past year.
IRTC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $108.1 | 13% below |
| 20 week MA | $114.6 | 18% below |
| 50 week MA | $127.7 | 27% below |
| 100 week MA | $133.3 | 30% below |
| 200 week MA | $116.0 | 19% below |
IRTC is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
IRTC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $66.1 | $242.1 | +266% |
| 2021 | $242.1 | $118.8 | -51% |
| 2022 | $118.8 | $95.2 | -20% |
| 2023 | $95.2 | $107.0 | +12% |
| 2024 | $107.0 | $88.8 | -17% |
| 2025 | $88.8 | $176.6 | +99% |
| 2026 YTD | $176.6 | $93.6 | -47% |
IRTC's yearly returns have swung widely, from +266% in 2020 to −51% in 2021. It's down 47% so far in 2026.